For years, many Medicare Advantage organizations treated HCC risk adjustment as a volume exercise: capture more diagnoses, lift RAF scores, and increase reimbursement. That approach still looks attractive on paper, but in 2026 it’s increasingly unsustainable. CMS audit activity has intensified, CMS-HCC Version 28 has reshaped risk coefficients and mappings, and quality programs like HEDIS are more tightly linked to accurate documentation. The result: the question has shifted from “Was the diagnosis submitted?” to “Can the diagnosis survive scrutiny?”

In 2025, U.S. hospitals spent $18 billion overturning claims denials. Not losing those claims. Not writing them off. Ov...
read more
Revenue is disappearing long before denials ever hit a ledger. Hospitals and health systems still rely heavily on retros...
read more
Here's a question your AR team probably isn't asking: which unpaid claim is most likely to block your cash flow this wee...
read more
You’re leaving $25-$40 per visit on the table every time a legitimate 99214 gets downcoded to 99213. Not because someone...
read more
Account receivable services don’t often feature prominently in legal proceedings, but a recent case from Ardent Health b...
read more
The home health revenue cycle has officially entered its “Prove It” era. For years, many home health agencies approache...
read more
The conversation around fraud in laboratory billing, especially in genetic and molecular diagnostics, is no longer theor...
read more
In today’s US healthcare market, laboratory revenue cycle management (lab RCM) is no longer just about clean billing – i...
read more
The healthcare revenue cycle has recently seen a flurry of coding solutions from some of the most recognized names in AI...
read more